Caas Capital Management LP Guardant Health, Inc. Transaction History

Caas Capital Management LP

  • $895 Million
  • Q1 2025

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$98.77 - $132.17 $6.23 Million - $8.34 Million
-63,095 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$109.77 - $165.68 $6.93 Million - $10.5 Million
63,095 New
63,095 $7.84 Million
Q3 2020

Nov 09, 2020
SELL
$80.32 - $111.8 $9.42 Million - $13.1 Million
-117,242 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$60.49 - $97.5 $7.09 Million - $11.4 Million
117,242 New
117,242 $9.51 Million

Others Institutions Holding GH

# of Institutions
452
Shares Held
125M
Call Options Held
2.18M
Put Options Held
2.69M
View Full List

About Guardant Health, Inc.

GH Quotes by TradingView
  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $9.65B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Caas Capital Management LP Portfolio

Follow Caas Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caas Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Caas Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email